Reversed-Phase HPLC Column Selection for Peptide Purity Analysis: C18 Bonding, Pore Size, and Particle Size Explained

Educational information for a laboratory audience. Not medical advice, not a recommendation for human use. Peak Labs products are for laboratory research use only.

Reversed-phase high-performance liquid chromatography (RP-HPLC) is the workhorse method for assessing research peptide purity, but the column itself is often treated as an afterthought. In practice, the stationary phase chemistry, pore size, and particle size of an HPLC column determine whether closely related impurities such as deletion sequences or oxidised variants are resolved from the main peak at all. For laboratories reviewing a certificate of analysis, understanding how a column was selected helps explain why two purity values for structurally similar compounds can differ even when the underlying testing philosophy is the same.

Why Column Chemistry Matters for Peptide Analysis

A chromatography column separates molecules based on their differential interaction with a stationary phase as they are carried through by a mobile phase, typically a water and acetonitrile gradient with a small amount of trifluoroacetic acid or formic acid as an ion-pairing modifier. For small molecules, this separation is largely governed by hydrophobicity alone. Peptides are larger and more conformationally flexible, so their retention behaviour also depends on secondary structure, charge distribution along the backbone, and how readily the molecule can access the pores of the silica particle. A column optimised for small-molecule work can therefore give poor peak shape or incomplete resolution when applied to a peptide sample, even if the underlying method parameters look reasonable on paper.

C18 Bonding and Alternatives

C18, an octadecylsilane bonded phase, remains the default choice for peptide purity work because it offers strong retention across a wide range of peptide hydrophobicities and is well characterised across pharmacopeial methods referenced by USP. Shorter alkyl chains such as C8 or C4 reduce retention and can be useful for larger or more hydrophobic peptides that would otherwise bind too strongly to a C18 phase, sometimes failing to elute cleanly within a practical gradient. The choice between these phases is a method development decision made in view of the specific peptide's sequence and hydrophobicity, not a universal default.

Wide-Pore vs Narrow-Pore Silica

Pore size, typically reported in angstroms, determines whether a molecule can fully penetrate the internal surface area of the silica particle where most of the bonded phase resides. Narrow-pore silica, around 100 angstroms, is generally suited to small molecules and short peptides. Larger peptides can be excluded from these pores, interacting only with the outer surface and producing broad, poorly resolved peaks. Wide-pore silica, commonly 300 angstroms, is the standard recommendation for peptides above roughly 10 to 15 residues, since it allows the molecule to access the full stationary phase surface and improves both resolution and peak symmetry.

Particle Size and Resolution: HPLC vs UHPLC

Particle size directly affects chromatographic efficiency. Conventional HPLC columns typically use particles in the 3 to 5 micron range, while ultra-high-performance liquid chromatography (UHPLC) systems use sub-2-micron particles under substantially higher backpressure. Smaller particles increase the number of theoretical plates per unit column length, which sharpens peaks and improves the separation of closely eluting impurities such as single-residue deletion sequences. This is one reason a purity figure generated on a UHPLC system with a sub-2-micron column is not automatically comparable to one generated on an older HPLC platform with larger particles, even when both report area percent purity under an otherwise similar method.

Column Dimensions and Method Transfer

Internal diameter and column length also shape sensitivity and run time. Narrower-bore columns concentrate the sample into a smaller elution volume, improving detection sensitivity for limited sample amounts, while longer columns generally improve resolution at the cost of analysis time and solvent use. When a laboratory transfers a method between instruments or column lots, small differences in these dimensions, along with flow rate and gradient slope, can shift retention times and, in some cases, resolution of minor peaks. This is why a rigorous certificate of analysis will typically specify the column type, dimensions, and particle size alongside the chromatographic conditions rather than reporting a purity figure in isolation. Readers unfamiliar with how to interpret that level of method detail may find it useful to review how to read a peptide certificate of analysis alongside this article.

Linking Column Choice to Purity Reporting

Column selection is one input into the broader question of how a purity value is generated and what it actually represents. HPLC area percent purity, which measures the proportion of total peak area attributable to the main peak, is sensitive to how well the column resolves impurities from that main peak in the first place. A column poorly matched to the peptide's size or hydrophobicity can under-resolve impurities and artificially inflate an area percent figure. This is a separate consideration from mass-based identity confirmation, and the relationship between the two techniques is discussed in more depth in HPLC vs mass spectrometry for verifying peptide purity and identity.

Sourcing Documentation from Suppliers

Laboratories evaluating a supplier's testing rigor can reasonably ask which column chemistry, pore size, and particle size were used to generate a reported purity value, and whether that method is consistent across batches of the same compound. Consistent method parameters make batch-to-batch comparisons meaningful; a change in column type between testing events without documentation can make purity trends difficult to interpret. Peak Labs maintains testing documentation for the compounds listed across its research catalogue, and researchers can review general documentation practices on the certificate of analysis page.

Sources and further reading

• USP: United States Pharmacopeia
• IUPAC: International Union of Pure and Applied Chemistry
• PubChem
• NIST Chemistry WebBook

Research use only. Peak Labs products are supplied strictly for in-vitro laboratory research. They are not medicines or supplements, are not for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any condition.